According to the Merriam-Webster Dictionary, the English noun “solution” refers to: i) an action or process of solving a problem, ii) a bringing or coming to an end or into a state of discontinuity, iii) …
We are delighted to welcome Dr. Uwe Gottschalk to Biovian’s Board of Directors. “At Keensight, we are very pleased to welcome Uwe to the Board of Biovian” said Dr. Pierre Remy, Chairman of the Board. …
Biovian is looking forward to participating in the BIO International Convention on June 13th-16th in San Diego. #BIO2022 is back in person. Biovian representatives, CBO Magnus Gustafsson and Head of Business Development Eero Mustalahti are …
Viral contaminations are rare events in biopharmaceutical manufacturing, but regulatory agencies expect all biologics to undergo viral clearance testing to mitigate the risk of contamination [1, 2]. Therapies based on viral vectors have a small …
The article discusses the reasons behind the growing need for viral vectors and how Biovian, as a CDMO has taken actions to solve the manufacturing bottleneck. Antti Nieminen, CEO of Biovian: “The majority of Biovian’s customers …
What is the first thing that comes to your mind when you think about a warehouse? Maybe an image of a truck stacking pallets and boxes in a giant hall? However, the warehouse at Biovian …
Outsourcing as a business model within the Life Science-industry is growing year by year. Choosing the right contract development and manufacturing organization (CDMO) has become an important factor for the success of drug product development. …
Here we present some basic concepts of Viral Vectors used in gene therapy applications with special focus on AAV and Adenovirus vectors. Please proceed to this page if you are looking for information about our …
The whys and the whats of GMP production of biopharmaceuticals. Why’d you have to go and make things so complicated? This chorus of the pop-rock song, Complicated, may reflect the thoughts of drug developers when …
GEN, one of the biggest biotech magazines interviewed Biovian about the critical bottlenecks in Adeno-associated virus (AAV) Manufacturing. AAVs, gene therapy and manufacturing technologies are two of the “hottest” biotech areas in the industry right …
